The Senate Finance Committee today held a hearing on the Children’s Health Insurance Program, which covers 8.9 million children with family incomes above Medicaid eligibility limits who lack access to affordable private coverage. While the program is authorized through Oct. 1, 2019, legislative action is needed to continue funding beyond this month. The Medicaid and CHIP Payment and Access Commission, created by the CHIP Reauthorization Act of 2009 to advise Congress on issues affecting Medicaid and CHIP, projects that three states and the District of Columbia will exhaust available federal funds in the first quarter of FY 2018 and another 27 will do so in the second quarter. Committee Chairman Orrin Hatch (R-UT), who with Sen. Ted Kennedy (D-MA) led bipartisan efforts to establish the program in 1997, said, “The basic question is: Does the committee want to reauthorize or merely extend CHIP? Reauthorization would entail more extensive debate and the consideration of potential policy changes to the underlying program.” Sen. Ron Wyden (D-OR), ranking member of the committee, said, “It’s important for Congress to take action soon. There’s no kicking this can down the road with a short-term bill.” Testifying at the hearing were the mother of a CHIP recipient and officials from MACPAC and the Virginia Department of Medical Assistance Services. For more on CHIP, see the AHA’s new infographic.

Headline
The Centers for Medicare & Medicaid Services Nov. 13 announced it will delay enforcement of its Medicaid community engagement requirements that are set for…
Headline
The AHA Nov. 13 released “Interoperability and Prior Authorization: The American Hospital Association’s 2027 Guide to Electronic Prior Authorization Go-live…
Headline
The Department of Health and Human Services Nov. 12 made two announcements  regarding the development of mental health treatments for veterans and other…
Headline
Bill Gassen, president and CEO of Sanford Health and AHA chair-elect, will participate in a panel discussion during the 2026 Milken Institute Future of Health…
Headline
The Centers for Medicare & Medicaid Services Nov. 5 published a final rule to codify the Medicare Drug Price Negotiation Program beginning in 2029. The…
Headline
The estimated average monthly premium for Medicare Part D stand-alone prescription drug plans is $51 for 2027, a 50% increase from $34 in 2026, for enrollees…